Skip to main content
Terug
Watch Compare

PANACEA LIFE SCIENCES HOLDINGS, INC.

Datakwaliteit: 100%
PLSH
OTC Manufacturing Chemicals
€ 0,04
€ 0,00 (0,00%)
Marktkapitalisatie: 827.727,0
Prijs
€ 0,04
Marktkapitalisatie
827.727,0
Dagbereik
€ 0,04 — € 0,05
52-Weeksbereik
€ 0,03 — € 0,20
Volume
29.999
Openen € 0,05
50D / 200D Gem.
€ 0,04
10,96% below
50D / 200D Gem.
€ 0,05
28,04% below

Quick Summary

Belangrijkste Punten

Revenue grew 62,07% annually over 5 years — strong growth
Negative free cash flow of -1,62 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 15,48%
Capital efficient — spends only 1,99% of revenue on capex

Groei

Revenue Growth (5Y)
62,07%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)46,59%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-277,51%
Op. Margin-192,25%

Veiligheid

Debt / Equity
N/A
Current Ratio0,23
Interest Coverage-3,31

Waardering

PE (TTM)
-0,11
Boven sectorgemiddelde (-1,47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -0,1 -1,5
P/B — 1,6
ROE % — -53,5
Net Margin % -277,5 -41,5
Rev Growth 5Y % 62,1 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 46,59% Revenue Growth (3Y) 7,61%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 62,07% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2,76 M Net Income (TTM) -7,67 M
ROE N/A ROA -42,44%
Gross Margin 56,53% Operating Margin -192,25%
Net Margin -277,51% Free Cash Flow (TTM) -1,62 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,23
Interest Coverage -3,31 Asset Turnover 0,15
Working Capital -15,75 M Tangible Book Value -15,65 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,11 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,30
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -196,06%
Market Cap 827.727,0 Enterprise Value 720.084,0
Per Share
EPS (Diluted TTM) -0,57 Revenue / Share 0,13
FCF / Share -0,08 OCF / Share -0,07
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1,99% FCF Conversion 21,16%
SBC-Adj. FCF N/A Growth Momentum -15,48

Income Statement

Annual, most recent first
Metric FY2023 FY2022 FY2021 FY2020 FY2019
Revenue 2,38 M 1,63 M 2,06 M 2,07 M 345.680,0
Net Income -8,02 M -9,14 M -4,78 M -10,94 M -10,22 M
EPS (Diluted) -0,48 — — — —
Gross Profit 1,12 M 396.470,0 540.578,0 -648.616,0 -1,70 M
Operating Income -5,55 M -5,65 M -5,94 M -10,55 M -10,88 M
EBITDA — — — — —
R&D Expenses — — — 0,0 22.100,0
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 1,56 M 2,05 M 1,11 M 1,00 M 479.111,0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2023 FY2022 FY2021 FY2020 FY2019
Total Assets 17,98 M 19,49 M 23,78 M 71.268,0 9,80 M
Total Liabilities 26,27 M 21,63 M 16,68 M 5,11 M 6,12 M
Shareholders' Equity -8,29 M -2,14 M 7,10 M -3,26 M 4,22 M
Total Debt — — — 335.510,0 185.906,0
Cash & Equivalents 100.922,0 6.951,0 19.774,0 25.139,0 18.405,0
Current Assets 4,66 M 6,38 M 9,10 M 51.109,0 2,43 M
Current Liabilities 19,45 M 15,07 M 10,07 M 4,90 M 4,19 M